CABG | Coronary Artery Bypass Grafting Results (Open Heart Surgery)

Why is Measuring CABG Results Important?

Surgery Patients Receiving Beta Blocker Therapy is a National Quality Forum endorsed measure and part of the medication bundle in the STS Composite Quality Rating (Star Rating). Beta blockers have been proven to increase survival in cardiac patients. Also are used for the treatement of high blood pressure, treating chest pain/angina, controlling irregular heart rhythms, prevention of postoperative atrial fibrillation, slowing ventricular rate response, and treating congestive heart failure.

Internal Mammary Artery (IMA) Usage is a National Quality Forum endorsed measure and Physician Quality Reporting System individual measure used to show the number of patients aged 18 years and older undergoing Coronary Artery Bypass surgery who received an Internal Mammary Artery graft (IMA). Patients who have repeat CABG surgery and documentation of medical reason(s) for not performaing an IMA graft are excluded from the procdure count. Acceptable medical reasons include, subclavian stenosis, previous cardiac or thoracic surgery, previous mediastinal radiation, emergent or salvage procedures, no bypassable left anterior descending artery (LAD) disease. The IMA as a graft is considered to be more cost effective in comparison to cardiac catheterization with placement of stents or medical therapy.

CABG Results April – June 2019

Clinical Indicator
St. Dominic's
National Avg.
CABG SIR
(SIR) Standardized Infection Ratio
Not calc
N=2
0.55
CABG
Patient Receiving Correct Disharge Medications
96.8%
92.5%
CABG Readmissions
Within 30 days
5.6%
12.8%
STS - Society of Thoracic Surgeons
The clinical indicators assess surgical performance for the adult cardiac outcomes for CABG.
STS reports the outcomes of these Quality Measures to CMS and MIPS.
The STS National
Database has been designated a Qualified Clinical Data Registry for MIPS reporting in 2017.
The indicators are monitored and reported quarterly at the CV Task Group meetings.
Clinical Indicator
St. Dominic’s
National Avg.
CABG
Surgery Patients Receiving BB Therapy
100%
99%
CABG Readmission
Within 30 days
11.42%
13.73%
Surgery Patients Who Received IMA Graft
100%
99%
Clinical Indicator
St. Dominic’s
National Avg.
CABG
Surgery Patients Receiving BB Therapy
100%
94.7%
CABG Readmission
Within 30 days
15.8%
< 12%
Surgery Patients Who Received IMA Graft
100%
99%
Clinical Indicator
St. Dominic’s
National Avg.
CABG
Surgery Patients Receiving BB Therapy
99%
100%
CABG Readmission
Within 30 days
3%
< 12%
Surgery Patients Who Received IMA Graft
100%
100%
Clinical Indicator
St. Dominic’s
National Avg.
CABG
(SIR) Standardized Infection Ratio
SIR= n/a
N=2
0.55
CABG
Surgery Patients Receiving BB Therapy
99%
100%
CABG Readmission
Within 30 days
3%
< 12%
Surgery Patients Who Received IMA Graft
100%
100%
Clinical Indicator
St. Dominic’s
National Avg.
CABG
(SIR) Standardized Infection Ratio
SIR= n/a
N=2
0.55
CABG
Surgery Patients Receiving BB Therapy
100%
100%
CABG Readmission
Within 30 days
8.47%
11 – internal%
Surgery Patients Who Received IMA Graft
99%
100%
Clinical Indicator
St. Dominic’s
National Avg.
CABG SIR
(SIR) Standardized Infection Ratio
N=1
0.55
CABG
Surgery Patients Receiving BB Therapy
99.1%
98.36
CABG Readmission
Within 30 days
7.98%
Not Available
Surgery Patients Who Received IMA Graft
100%
99.10%
Clinical Indicator
St. Dominic’s
National Avg.
CABG SIR
(SIR) Standardized Infection Ratio
N=0
0.55
CABG
Surgery Patients Receiving BB Therapy
98.25%
92.30
CABG Readmission
Within 30 days
6.97%
Not Available
Clinical Indicator
St. Dominic’s
National Avg.
CABG SIR
(SIR) Standardized Infection Ratio
N=0
0.55
CABG
Surgery Patients Receiving BB Therapy
98.2%
92.3
CABG Readmission
Within 30 days
5.9%
13.2%